Biosimulation is PC aided mathematical simulation of biological structures and methods. Biosimulation is used for version based total calculation of biological structures. The primary motive for the development of biosimulation is the growing use of pharmacodynamic and pharmacokinetic (PKPD) model in pre-scientific drug development. Biosimulation refers to simulation of biological procedures by using laptop application. Biosimulation technology has wide utility in drug discovery and development. Its miles a predictive device and used in discovery level to decide the destiny effects of current experimental trials.
How Big is the Global Biosimulation Technology Market?
The Global Biosimulation Technology Market is expected to exceed more than US$ 6083 million by 2028 and will grow at a CAGR of more than 15% in the given forecast period.
The major driving factors of Global Biosimulation Technology Market are as follows:
• High healthcare expenditure
• Enhanced simulation technology
• Advanced software programs
The restraining factors of global Biosimulation Technology market are as follows:
• Lack of standard method for biosimulation
• High risk of failure of drugs in biosimulation
The Global Biosimulation Technology Market is segmented on the lines of its application and regional. Application segmentation is further classified into drug discovery and drug development. Drug discovery is classified into lead identification, target identification, lead optimization and target validation. Under drug development segmentation it covers in patient validation and preclinical testing and clinical trials. The Global Biosimulation technology market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Biosimulation Technology Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Biosimulation Technology Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Biosimulation Technology Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Accelrysinc., Schrodinger, ACD/Labs, LeadScope, Certara, Rhenovia, Archimedes, Genedata and Insilico BioTechnology. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Biosimulation Technology Market has been segmented as below:
By Application Analysis
• Drug Discovery
o Lead Identification
o Target Identification
o Lead Optimization
o Target Validation
• Drug Development
o In Patient Validation
o Preclinical Testing and Clinical Trials
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Biosimulation Technology Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Biosimulation Technology Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Clopidol (CAS 2971-90-6) Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Lucrative Opportunities in the Global Biosimulation Market
4.2 Life Cycle Analysis, By Region
5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Product
5.2.2 By Application
5.2.3 By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Growth in the Pharmaceutical and Biotechnology Industries
5.3.1.2 Increase in R&D Investments in the Pharmaceutical and Biotechnology Industries
5.3.1.3 Technological Advancements
5.3.1.4 Need to Curtail Drug Discovery and Development Costs
5.3.1.5 Growth in the Biologics and Biosimilars Market and Increased Use of Personalized Medicines
5.3.2 Restraints
5.3.2.1 Lack of Standardization
5.3.2.2 Lack of Trained Professionals
5.3.3 Opportunities
5.3.3.1 Emerging Applications
5.3.4 Challenges
5.3.4.1 Limited Knowledge of Biological Systems and Processes
5.3.5 Trends
5.3.5.1 Collaborations of Universities and Research Labs With Suppliers
6 Biosimulation Market, By Product
6.1 Introduction
6.2 Software
6.2.1 PK/PD Modeling and Simulation Software
6.2.2 Molecular Modeling and Simulation Software
6.2.3 Pbpk Modeling and Simulation Software
6.2.4 Toxicity Prediction Software
6.2.5 Trial Design Software
6.2.6 Other Software
6.3 Services
6.3.1 In-House Services
6.3.2 External/Contract Services
7 Biosimulation Market, By Application
7.1 Introduction
7.2 Drug Development
7.2.1 Preclinical Testing
7.2.1.1 PK/PD
7.2.1.2 ADME/TOX
7.2.2 Clinical Trials
7.3 Drug Discovery
7.3.1 Target Identification and Validation
7.3.2 Lead Identification and Optimization
7.4 Other Applications
8 Biosimulation Market, By End User
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Academic and Government Research Institutes
8.4 Contract Research Organizations
8.5 Regulatory Authorities
8.6 Other End Users
9 Global Biosimulation Market, By Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.1 Introduction
10.2 Strategic Overview
10.3 Leading Players in the Biosimulation Market
10.4 Competitive Situation and Trends
10.4.1 Product Upgradation
10.4.2 Agreements, Collaborations, Expansions, and Partnerships
10.4.3 New Product and Service Launches
10.4.4 Acquisitions
10.4.5 Other Developments
11 Company Profiles
11.1 Introduction
11.2 Certara USA, Inc.
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments
11.3 Simulation Plus Inc.
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments
11.4 Dassault Systèmes SA
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments
11.5 Schrödinger Inc.
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments
11.6 Advanced Chemistry Development, Inc.
11.6.1 Business Overview
11.6.2 Products Offered
11.6.3 Recent Developments
11.7 Chemical Computing Group, Inc.
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments
11.8 Entelos Holding Corporation
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments
11.9 Genedata Ag
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments
11.10 Physiomics PLC
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments
11.11 Rhenovia Pharma Ltd.
11.11.1 Business Overview
11.11.2 Products Offered
11.11.3 Recent Developments
The Global Biosimulation Technology Market has been segmented as below:
By Application Analysis
• Drug Discovery
o Lead Identification
o Target Identification
o Lead Optimization
o Target Validation
• Drug Development
o In Patient Validation
o Preclinical Testing and Clinical Trials
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
